Regulated cell death pathways in kidney disease.
Sanz AB, Sanchez-Niño MD, Ramos AM, Ortiz A.
Nat Rev Nephrol. 2023 May;19(5):281-299. doi: 10.1038/s41581-023-00694-0. Epub 2023 Mar 23.
Glucarpidase for treatment of high-dose methotrexate toxicity.
Gupta S, Kaunfer SA, Chen KL, Dias JA, Vijayan A, Rajasekaran A, Prosek JM, Truong HL, Wood A, Bassil C, Renaghan AD, Shah CV, Zhang J, Glezerman I, Carlos C, Kelly K, Passero CJ, Drappatz J, Abudayyeh A, Shin DS, Sperati CJ, Yelvington BJ, Kanduri SR, Neyra JA, Edmonston D, Shirali AC, Bansal A, Geara A, Mithani Z, Ziolkowski SL, Rashidi A, Jakubowski J, Pujari A, Bond DA, Dotson E, Wall S, Patton J, Barreto JN, Herrmann SM, Sheikh MS, Baz R, Lee J, Lucchesi N, Kolman M, Rasheed MA, Afzal A, Kang D, Mahesh A, Hsu RK, Nicolaysen A, Tefera K, Schretlen C, Miller RM, Velez JC, Flannery AH, Aklilu AM, Anand S, Chandrasekhara S, Donley V, Patel A, Ni J, Krishnamurthy S, Ali R, Yilmam OA, Wells SL, Ortega JL, Green-Lingren OL, Leaf RK, Sise ME, Nayak L, LaCasce AS, Leung N, Leaf DE.
Blood. 2025 Apr 24;145(17):1858-1869. doi: 10.1182/blood.2024026211.
Hypertensive Crisis.
Ahmed I, Alley WD, Chauhan S, Afzal M.
2025 Dec 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Malignant hypertension: does this still exist?
Domek M, Gumprecht J, Lip GYH, Shantsila A.
J Hum Hypertens. 2020 Jan;34(1):1-4. doi: 10.1038/s41371-019-0267-y. Epub 2019 Oct 21.
Hemolytic Uremic Syndrome.
Bhandari J, Rout P, Sedhai YR.
2023 Oct 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
MAP3K kinases and kidney injury.
Cuarental L, Sucunza-Sáenz D, Valiño-Rivas L, Fernandez-Fernandez B, Sanz AB, Ortiz A, Vaquero JJ, Sanchez-Niño MD.
Nefrologia (Engl Ed). 2019 Nov-Dec;39(6):568-580. doi: 10.1016/j.nefro.2019.03.004. Epub 2019 Jun 10.
Scleroderma renal crisis.
Hudson M, Ghossein C, Steen V.
Presse Med. 2021 Apr;50(1):104063. doi: 10.1016/j.lpm.2021.104063. Epub 2021 Feb 3.
Characteristics and Outcome of Biopsy-proven Malignant Hypertension with Severe Kidney Injury: A Retrospective Study.
Haridasan S, Priyamvada PS, Puthiyottil D, Pradeep A, Parameswaran S, Srinivas BH, Ganesh RN.
Indian J Nephrol. 2021 Sep-Oct;31(5):467-473. doi: 10.4103/ijn.IJN_187_20. Epub 2021 Apr 10.
Myeloma-related kidney disease.
Leung N, Nasr SH.
Adv Chronic Kidney Dis. 2014 Jan;21(1):36-47. doi: 10.1053/j.ackd.2013.08.009.
Clinicopathological Characteristics and Prognosis of IgA Nephropathy Combined With Malignant Hypertension Kidney Injury.
Zhong Z, Yang W, Dai Z, Li J, Li Z.
J Clin Lab Anal. 2025 Oct;39(20):e70105. doi: 10.1002/jcla.70105. Epub 2025 Sep 19.
